One would expect that if abnormal localization of BSEP is part of the mechanism underlying MYO5B-associated cholestasis, BSEP IHC results and the MYO5B genetic variations might similarly be linked to their clinical and biochemical disease features. This evidence concerns the gene MYO5B and cholestasis.